Population
In vitro model usingCr-labeled platelets and monolayers of cultured human endothelial, fibroblast, and…
Comparison
Aspirin (1-2 mM and 0.1 mM) vs Untreated monolayers
Design
Preclinical
Authors
Loading...
High-dose aspirin may enhance platelet adherence in vitro; leaves open translation to clinical dosing or in vivo thrombosis.
In vitro, high concentrations of aspirin (1-2 mM) enhance thrombin-induced platelet adherence to endothelial cells, while lower concentrations (0.1 mM) inhibit platelet malonaldehyde production without impairing endothelial anti-adherence properties.
Czervionke et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: